3D Bioprinting Industry To Observe Fastest Growth In Asia-Pacific

The 3D bioprinting industry will reach a value of USD 5,873 million by 2030, propelling at a rate of 19.4%, as per a report by a market research institution, P&S Intelligence.

To learn more about this report: https://bit.ly/3pps5pK

Factors such as the development of 3D biomaterials and bioprinters, the increasing investment by the public and private sectors for bioprinting research activities, and their usage of the same in the cosmeceutical and pharmaceutical industries are positively influencing the industry.

The increasing incidence of chronic disorders and the shortage of organ donors are also boosting the growth of the industry.

The demand for important body parts for transplantation is significantly high. The supply and demand gap for organs and tissues for transplantation is also huge. Kidneys, liver, intestines, heart, and pancreas, are mainly required for transplantation. 

The North American 3D bioprinting market held a share of approximately 40% in recent years. This is credited to the increasing R&D activities, developing healthcare infrastructure, and technological advancements. 

In addition, the increasing elderly population, the increasing incidence of chronic disorders, and the high healthcare expenditure are boosting the demand for this technology in the region. 

Asia-Pacific is expected to witness the fastest growth in the industry, mainly due to the increasing research and development, support and tax benefits by the government, and a large customer base. 

The inkjet technology prints complex tissues and organs on culture substrates by using living cells as bio-inks. The inkjet printers offer high reliability, thus the adoption of these printers in the medical industry has increased significantly.

Some of the key players in the industry are:

1- BICO Group AB

2- Organovo Inc.

3- 3D Systems Corporation

4- regenHU Ltd.

5- Desktop Metal Inc.

6- Cyfuse Biomedical K.K.

7- Tissue Regeneration Systems Inc.

It is due to the high demand for organ and tissue transplants, increasing drug discovery activities, and the increasing elderly population all over the globe, the 3D bioprinting industry will grow significantly in the coming years.